Suppr超能文献

在服务不足的城市人群中,患有 COVID-19 感染的危重症个体的临床特征、呼吸力学和结局。

Clinical Characteristics, Respiratory Mechanics, and Outcomes in Critically Ill Individuals With COVID-19 Infection in an Underserved Urban Population.

机构信息

Division of Pulmonary and Critical Care and Sleep Medicine, Einstein Medical Center, Philadelphia, Pennsylvania.

Department of Medicine, Einstein Medical Center, Philadelphia, Pennsylvania.

出版信息

Respir Care. 2021 Jun;66(6):897-908. doi: 10.4187/respcare.08319. Epub 2021 Jan 14.

Abstract

BACKGROUND

The COVID-19 outbreak in the United States has disproportionately affected Black individuals, but little is known about the factors that underlie this observation. Herein, we describe these associations with mortality in a largely minority underserved population.

METHODS

This single-center retrospective observational study included all adult subjects with laboratory-confirmed SARS-Cov-2 treated in our ICU between March 15 and May 10, 2020.

RESULTS

128 critically ill adult subjects were included in the study (median age 68 y [interquartile range 61-76], 45% female, and 64% Black); 124 (97%) required intubation. Eighty (63%) subjects died during their in-patient stay, which did not differ by race/ethnicity. Compared with other racial/ethnic groups, Blacks had a greater proportion of women (52% vs 30%, = .02) and subjects with hypertension (91% vs 78%, = .035). Asthma ( = .03) was associated with lower in-patient death, primarily among Black subjects ( = .02). Among Black subjects, increased age (odds ratio 1.06 [95% CI 1.05-1.22] per year), positive fluid balance (odds ratio 1.06 [95% CI 1.01-1.11] per 100 mL), and treatment with tocilizumab (odds ratio 25.0 [95% CI 3.5-180]) were independently associated with in-patient death, while higher platelets (odds ratio 0.65 [95% CI 0.47-0.89] per 50 × 10/mL) and treatment with intermediate dose anticoagulants (odds ratio 0.08 [95% CI 0.02-0.43]) were protective. Among other race/ethnic groups, higher total bilirubin (odds ratio 1.75 [95% CI 0.94-3.25] per 0.2 mg/dL) and higher maximum lactate (odds ratio 1.43 [95% CI 0.96-2.13] per mmol/L) were marginally associated with increased death, while tocilizumab treatment was marginally protective (odds ratio 0.24 [95% CI 0.05-1.25]). During first 72 h of ventilation, those who died had less increase in [Formula: see text] ( = .046) and less reduction in PEEP ( = .01) and [Formula: see text] requirement ( = .002); these patterns did not differ by race/ethnicity.

CONCLUSIONS

Black and other race/ethnicity subjects had similar mortality rates due to COVID-19 but differed in factors that were associated with increased risk of death. In both groups, subjects who died were older, had a positive fluid balance, and less improvement in [Formula: see text], PEEP, and [Formula: see text] requirement on ventilation.

摘要

背景

美国的 COVID-19 疫情对黑人个体的影响不成比例,但人们对导致这一观察结果的因素知之甚少。在此,我们描述了这些与死亡率之间的关联,这是在一个主要由少数民族和服务不足的人群中进行的。

方法

这是一项单中心回顾性观察研究,纳入了 2020 年 3 月 15 日至 5 月 10 日期间在我们 ICU 接受实验室确诊的 SARS-CoV-2 治疗的所有成年患者。

结果

共纳入了 128 例危重症成年患者(中位年龄 68 岁[四分位间距 61-76],45%为女性,64%为黑人);124 例(97%)需要插管。在住院期间,80 例(63%)患者死亡,其死亡率与种族/民族无关。与其他种族/民族相比,黑人中女性比例较高(52% vs. 30%, =.02),高血压患者比例较高(91% vs. 78%, =.035)。哮喘( =.03)与住院死亡率降低有关,主要是在黑人患者中( =.02)。在黑人患者中,年龄每增加 1 岁(优势比 1.06[95%置信区间 1.05-1.22])、正液体平衡(优势比 1.06[95%置信区间 1.01-1.11]每 100 毫升)和使用托珠单抗(优势比 25.0[95%置信区间 3.5-180])与住院死亡率独立相关,而血小板计数较高(优势比 0.65[95%置信区间 0.47-0.89]每 50×10/mL)和使用中等剂量抗凝剂(优势比 0.08[95%置信区间 0.02-0.43])与死亡率降低有关。在其他种族/民族中,总胆红素较高(优势比 1.75[95%置信区间 0.94-3.25]每 0.2 毫克/分升)和最大乳酸较高(优势比 1.43[95%置信区间 0.96-2.13]每 mmol/L)与死亡率增加相关,而托珠单抗治疗有轻微保护作用(优势比 0.24[95%置信区间 0.05-1.25])。在通气的前 72 小时内,死亡患者的 [Formula: see text]( =.046)增加较少,PEEP( =.01)和 [Formula: see text]需求( =.002)减少较少;这些模式在种族/民族之间没有差异。

结论

黑人及其他种族/民族的 COVID-19 死亡率相似,但与死亡率增加相关的因素不同。在这两个组中,死亡患者年龄较大,液体平衡为正,并且在通气期间 [Formula: see text]、PEEP 和 [Formula: see text]需求的改善较少。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验